FSA bans six for distorting financial results

The Financial Services Authority (FSA) has banned six former directors of a UK insurance company called Chiyoda Fire and Marine Insurance Company (Europe) Limited (CE) for their role in distorting the financial results of CE during 1999 and 2000. CE is currently known as Aioi Insurance Company of Europe (AE). This is the FSA's first enforcement action in relation to senior management of an insurance company.

Three individuals, Mr Yoshiaki Yamazaki, Mr Hiroshi Okazaki and Mr Robert McKibbin have been prohibited from performing any functions in relation to any regulated activity carried on by any authorised

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Regulator delays general insurance stress test

The Prudential Regulation Authority has postponed the dynamic general insurance stress test launch as switching from Solvency II to Solvency UK reporting requirements mean providers have enough on their plate in 2025.

Insurance Post’s Christmas Special Podcast

Post content director Jonathan Swift, news editor Scott McGee and Emma Ann Hughes, editor, ditch the usual format of our publication’s award-winning podcast to deliver a holly, jolly Christmas Special.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here